Your browser doesn't support javascript.
loading
In patients with well-differentiated neuroendocrine tumours, there is no apparent benefit of somatostatin analogues after disease control by peptide receptor radionuclide therapy.
Sygula, Aleksandra; Ledwon, Aleksandra; Hasse-Lazar, Kornelia; Jurecka-Lubieniecka, Beata; Michalik, Barbara; Paliczka-Cieslik, Ewa; Zeman, Marcin; Chmielik, Ewa; Sczasny, Joanna; Jarzab, Barbara; Handkiewicz-Junak, Daria.
Afiliación
  • Sygula A; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Ledwon A; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Hasse-Lazar K; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Jurecka-Lubieniecka B; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Michalik B; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Paliczka-Cieslik E; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Zeman M; The Oncologic and Reconstructive Surgery Clinic, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Chmielik E; Tumor Pathology Department, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Sczasny J; Radiology and Diagnostic Imaging Department, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Jarzab B; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland.
  • Handkiewicz-Junak D; Department of Nuclear Medicine and Endocrine Oncology, Gliwice Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 16, 44-101, Gliwice, Poland. daria.handkiewicz-junak@io.gliwice.pl.
Eur J Nucl Med Mol Imaging ; 49(11): 3841-3851, 2022 09.
Article en En | MEDLINE | ID: mdl-35503379
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Somatostatina / Tumores Neuroendocrinos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2022 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Somatostatina / Tumores Neuroendocrinos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2022 Tipo del documento: Article País de afiliación: Polonia